Recombinant CCN2 (Pamrevlumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CCN2 (Pamrevlumab Biosimilar) products
- CCN2 (Pamrevlumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CCN2 (Pamrevlumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA, Western Blotting (WB)
- Purpose
- Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CCN2 (Pamrevlumab Biosimilar)
- Abstract
- CCN2 (Pamrevlumab Biosimilar) Products
- Background
- Pamrevlumab is a recombinant human antibody that binds to connective tissue growth factor (CTGF). It can be used for the research of idiopathic pulmonary fibrosis (IPF).
- CAS-No
- 946415-13-0
-
You are here:
